View this email in your browser

IowaBio Monthly Newsletter

October 2020



At the direction and approval of our planning committee, IowaBio has decided to rename and rebrand its annual conference, formerly known as Partnering for Growth. Partnering for Growth began in 2011 with a focus on fostering public and private partnerships. Over the years, it has evolved into the state's leading biotech conference, catering educational and networking opportunities to multiple bioscience industries including food and ag, industrial and environmental, human and animal health, ag tech, and med device. 

In 2016, we introduced the Biotech Showcase to the event, a start-up pitch competition bringing innovators, investors, and industry experts together for a day of pitch presentations and awards. 

As the Biotech Showcase grew and educational Tracks continued to be top features of the event, we made the decision to move forward with a name that better highlighted the event's activities and focus.

We are excited to announce that Partnering for Growth will now be known as the Iowa Biotech Showcase & Conference (IBSC)! IBSC will be hosted virtually in March of 2021 and you will see two participation opportunities announced next week: 
  • A call for Biotech Showcase applications from start-up companies
  • A call for Track presentation proposals from industry and support experts
We encourage you to keep an eye out for these announcements, apply your company and/or submit your proposal for consideration, and spread the word with your colleagues!
On September 22nd, IowaBio partnered with the NIH National Center for Advancing Translational Sciences (NCATS) to host a free Small Business Funding webinar for our members and industry partners.

Over 40 people registered to hear Lili Portilla, Director of the NCATS Office of Strategic Alliances, present an overview of the Small Business Innovation Research and Small Business Technology Transfer (SBIR/STTR) programs. Topics discussed included key research focus areas, tips for submitting a successful application, upcoming funding opportunities and other NCATS resources and programs for researchers and entrepreneurs. Registrants were also encouraged to submit personalized questions, which were addressed during the webinar. 

Thank you to Lili Portilla and our friends at NCATS for making this opportunity available to our state!
The IowaBio Board of Directors at their September 17 meeting approved the IowaBio 2021 Legislative priorities as developed and approved by the IowaBio Government Affairs Committee on September 8. The Government Affairs Committee in the priorities elevated work surrounding public health related to vaccines, in light of COVID-19 and the growing anti-vaccination movement in Iowa. In addition, the Committee added language to review any legislation affecting intellectual property. The priorities include:
  • Economic Development: Tax Credits and Tax Policy
  • Pharmaceuticals and Public Health: Drug Pricing, Vaccines, and Patient Access
  • Bioscience Talent Pipeline: STEM Education and Workforce Initiatives
  • Intellectual Property: IP Rights and Innovation Protection
In addition, Joe Hrdlicka of Genentech (current board member and former IowaBio Executive Director) has been elected the new Chair of the Government Affairs Committee. Congratulations to Joe and a big thank you to Kent Hartwig of REG who served in the role for several years.

IowaBio also held several meetings with key legislators to dialogue and show our member support for their efforts. Thank you to all who participated in these important meetings!
IowaBio Quarterly Board Meeting (via Zoom)
December 11, 2020  |  9:30 - 12:00
BioVantage Program
One of IowaBio's most popular membership benefits is access to incredible savings made available through our BioVantage Program contracts.  These savings include product discounts, free shipping, and single point-of-contact consultation on these services from the following vendors:
Learn more about each of our available contract vendors through our BioVantage Program and the savings they provide. If you would like to be connected with a contract vendor to learn more about their services and savings, please contact Melissa Moyer at or 515-327-9156.
Download Flier
Science is US is a foundation-supported effort that brings together a diverse group of science, engineering, industry, higher education and labor organizations to galvanize a broad, bipartisan political base of support for science and technology. The initiative is working towards two public policy goals—encouraging robust federal support for research and improving science and evidence-based decision making in public policy development. With policymakers requiring increased guidance on scientific issues, our goals have never been more essential. 

Learn More >

IowaBio thanks the following members for recently renewing:
Register to Attend Dickinson Law's Free Startup Legal Webinar
From ideas to implementation, all startups begin with an idea. But while you’re focusing on turning those ideas into reality, don’t forget about the legal issues that can have a real impact on your new venture. From founding issues and what type of legal representation you need, protecting your data and intellectual property, to tax considerations and employment matters for your new enterprise, you won’t want to miss the FREE Dickinson Law Startup Webinar on October 8th from 12:00 - 2:00 p.m. You’ll receive valuable, actionable information from legal counsel who regularly work with startups as they get their ideas off the ground. Learn more >
Cellular Engineering Technologies has Been Awarded a Phase 2 SBIR Grant from the National Institutes of Health to Improve Reproducible and Safer Pluripotent Stem Cells
Cellular Engineering Technologies (CET), a biotechnology company located in Coralville, Iowa, announces that it has received a Phase 2 SBIR grant from the National Institutes of Health (NIH) to develop commercially safer and more reproducible pluripotent stem cells. CET, which was co-founded by Dr. Alan Moy and Anant Kamath, received official notice that their grant entitled "Improving the Reproducibility and Genetic Stability of Induced Pluripotent Stem Cells (iPSC) and Differentiated Cells Through Oncogene-Free Reprogramming and Fully Human Growth Factors," was funded this month. Learn more >
Agilent Announces SureSelect XT HS2 RNA Reagent Kit, a Library Prep and Target Enrichment Solution for RNA-Seq
Agilent Technologies Inc. announced the release of the SureSelect XT HS2 RNA Reagent Kit. This solution features a modular design that enables a simple and parallel approach for both RNA and DNA samples, allowing customers to streamline and consolidate their workflow without losing time optimizing different kits for different sample types. It marks the latest development in Agilent’s ongoing effort to improve NGS applications and workflows, leveraging the performance and versatility of XT HS2 chemistry.  Learn more >
Lilly and Amgen Announce Manufacturing Collaboration for COVID-19 Antibody Therapies
Eli Lilly and Company and Amgen announced a global antibody manufacturing collaboration to significantly increase the supply capacity available for Lilly's potential COVID-19 therapies. Through this collaboration, the two companies will have the ability to quickly scale up production and serve many more patients around the world should one or more of Lilly's antibody therapies prove successful in clinical testing and receive regulatory approval.  Learn more >
Emerging Consumer Behavior Shifts: Six Ways Food & Beverage Innovation Is Evolving in the Face of COVID-19
ADM has identified six emerging behavioral changes that will power innovation and growth in the months ahead. “Consumers’ attitudes, priorities and behaviors are shifting significantly,” said Ana Ferrell, VP of Marketing, ADM. “This evolution is providing a unique opportunity for forward-looking food and beverage companies to bring a suite of trailblazing new products to market.”  Learn more >
U.S. Department of Commerce Invests $35 Million to Fuel High-Growth Entrepreneurship Across America
U.S. Secretary of Commerce Wilbur Ross today announced that 52 organizations — including nonprofits, institutions of higher education, and entrepreneurship-focused organizations — from 36 states will receive grants totaling $35 million to support entrepreneurship, acceleration of company growth, and increased access to risk capital across regional economies. Learn more >

The Session Bill Tracker is a weekly report issued every Friday during legislative session. It provides an update on state and federal activities as well as a tracking record of bills relevant to the biotech industry and IowaBio’s position. This report is best suited for government affairs representatives and biotech companies engaged in policy efforts. To view archives of this distribution of sign up for the communications, please click here.

Our Monthly Newsletter is a great resource to keep up with IowaBio's activities, member and industry news, as well as additional savings, educational and networking opportunities in your area and across the globe. To view archives of this distribution or sign up for the newsletter, please click here

Starting March 23rd, IowaBio began issuing daily updates to share the latest news surrounding the virus from the biotech industry's point of view. Topics covered include state, national and global updates, legislative activities on the state and federal level, IowaBio member efforts and innovations, helpful resources/media and more.

If you are an IowaBio member and wish to receive this daily communication, please email Melissa Moyer at Non-members can access the communications once they've been issued on our archives page.
Copyright © 2019 Iowa Biotechnology Association, All rights reserved.

Our mailing address is:
500 E Court Avenue, Suite 112
Des Moines, IA 50309-2057

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.